Tue Ngoc Hoang v. California State Board of Pharmacy

230 Cal. App. 4th 448
CourtCalifornia Court of Appeal
DecidedOctober 8, 2014
DocketG049275
StatusPublished
Cited by3 cases

This text of 230 Cal. App. 4th 448 (Tue Ngoc Hoang v. California State Board of Pharmacy) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Tue Ngoc Hoang v. California State Board of Pharmacy, 230 Cal. App. 4th 448 (Cal. Ct. App. 2014).

Opinion

Opinion

RYLAARSDAM, Acting P. J.

Plaintiff Tue Ngoc Hoang, a pharmacist doing business as Orange Pharmacy (Orange), appeals from a judgment denying his petition for a writ of mandate. The petition sought to overturn a decision by defendant California State Board of Pharmacy revoking plaintiff’s pharmacy license and Orange’s permit to operate a pharmacy. Plaintiff argues defendant’s decision was unduly harsh, not supported by the findings, and denied him due process. We disagree and affirm the judgment.

FACTS AND PROCEDURAL BACKGROUND

Plaintiff held a pharmacy license issued by defendant and was doing business as Orange under a permit defendant issued to it. As Orange’s *451 pharmacist-in-charge, plaintiff was responsible for the pharmacy’s compliance with the laws and regulations concerned with the operation of the business. (Bus. & Prof. Code, § 4113, subd. (c).)

In November 2007, defendant filed an “Accusation,” seeking to discipline plaintiff. The Accusation contained five counts. Four related to alleged unlawful and improperly documented drug transfers with another pharmacy.

A fifth count alleged plaintiff had engaged in dishonest, fraudulent or deceitful conduct. The Accusation alleged that during 2005 and 2006, Orange was not authorized to receive payments from CalOptima, an entity administering Medi-Cal benefits in Orange County, for filling qualified patients’ drug prescriptions. Orange nonetheless unlawfully received nearly $150,000 in CalOptima payments through a covert arrangement with another pharmacy named Pacific Pharmacy (Pacific).

An administrative law judge (ALJ) conducted a three-day hearing on the Accusation. Plaintiff appeared through counsel, but did not personally attend the hearing. The ALJ issued a proposed decision finding the unlawful drug transfer and documentation allegations unsupported by the evidence, but that Orange engaged in “dishonest conduct” concerning CalOptima payments for which plaintiff was “personally responsible.”

The ALJ’s decision cited the following evidence in support of the finding of dishonesty and fraud. Prior to 2005, plaintiff had a contract with the pharmacy benefits manager (PBM) that processed prescription drug claims for patients covered by CalOptima. That year CalOptima imposed a new condition, which required each pharmacy contracting with its PBM to permit onsite reviews of its operations as part of a fraud prevention program.

Pacific agreed to the new onsite review condition, but plaintiff objected to it and refused to renew his contract with CalOptima’s PBM. In April, CalOptima notified plaintiff that it had terminated Orange’s authorization to seek payment for filling its patients’ drug prescriptions.

To retain the patronage of Orange’s Medi-Cal patients, plaintiff entered into a surreptitious arrangement with Que Buu, Pacific’s pharmacist-in-charge, whereby Orange used Pacific’s billing authority to obtain payment for filling the drug prescriptions of persons covered by CalOptima. Under the arrangement, Orange created a set of labels containing its name, address, and phone number for each CalOptima-qualified patient for whom it filled a prescription. Orange sent Pacific a record of having filled the prescription and Pacific then created a duplicate set of prescription labels for the same patients. Using its label, Pacific applied to CalOptima’s PBM for payment, *452 thereby representing to the PBM that it had filled the prescription. Upon receiving payment from CalOptima for the drug prescriptions actually filled by Orange, Pacific then funneled the money to Orange. Both pharmacies maintained records of the prescriptions Orange sent to Pacific for collection, the reimbursements Pacific received from the PBM, and the payments Pacific made to Orange. To foster an appearance of legitimacy for this arrangement, Orange and Pacific also created documents such as refill pharmacy contracts, purchased and borrowed logs, returned to stock memoranda, and labels that incorrectly stated that prescriptions had been transferred.

At the hearing, defendant presented evidence that, between July and December 2005, payments from CalOptima’s PBM to Pacific increased from approximately $43,000 to over $73,000. One of defendant’s inspectors estimated 38 percent of Pacific’s reimbursements from CalOptima between August 2005 and November 2006 were for Orange-filled prescriptions. He prepared a tabulation of invoices Orange had provided to Pacific for billing CalOptima that totaled over $149,000.

During a September 2006 inspection of Pacific, one of defendant’s inspectors discovered a log for Orange’s prescriptions. Buu acknowledged the existence and purpose of the arrangement between Orange and Pacific. Subsequently, defendant’s inspectors visited Orange and spoke with Paul Hoang, plaintiff’s son and the pharmacy’s business manager.

Hoang testified at the hearing, claiming Orange and Pacific “[w]ere acting as refill pharmacies” for each other, “including . . . CalOptima patients.” He stated, “We never believed that what we did was wrong or dishonest.” But Buu contradicted Hoang, admitting Pacific billed CalOptima for drug prescriptions filled by Orange and denied Orange acted as a refill pharmacy for Pacific in 2005 and 2006.

In his proposed decision, the ALJ recommended plaintiff’s pharmacy license and Orange’s permit be revoked, but the revocations be stayed for five years with both placed on probation with certain conditions. Defendant timely issued an order of nonadoption of the ALJ’s proposed decision and stated it would decide the matter based on the record produced during the administrative hearing along with written argument from the parties.

After receiving briefs from both parties, defendant issued its decision revoking plaintiff’s license and Orange’s permit. Defendant’s factual findings largely repeated the ALJ’s findings. Citing its disciplinary guidelines, defendant found plaintiff’s conduct constituted a category III violation, which includes “fraudulent acts committed in connection[] with the licensee’s practice.” The minimum level of discipline for a category III violation is *453 revocation, stayed, three to five years’ probation, and 90 days of actual suspension. The maximum discipline is license revocation. Similar levels of discipline apply to a pharmacy permit.

Defendant gave the following explanation for revoking the license and permit; “In order to determine the appropriate measure of discipline, it is necessary to weigh and balance [plaintiff’s] violations of law as well as factors in justification, aggravation, or mitigation. Protection of the public is the Board’s highest priority. ...[][] [Plaintiff], as the owner and pharmacist-in-charge of Orange Pharmacy, is responsible for the dishonest and fraudulent acts attributable to both licenses. The cause for discipline proven is serious and demonstrates [plaintiff’s] willingness to commit dishonest acts for his own financial gain. In aggravation, these acts were also not isolated incidents, but rather occurred several times over many months and involved deliberate acts to deceive a public benefits program.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

IV Solutions v. Cal. Board of Pharmacy CA2/4
California Court of Appeal, 2020
Oduyale v. California State Board of Pharmacy
California Court of Appeal, 2019
Sternberg v. California State Board of Pharmacy
239 Cal. App. 4th 1159 (California Court of Appeal, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
230 Cal. App. 4th 448, Counsel Stack Legal Research, https://law.counselstack.com/opinion/tue-ngoc-hoang-v-california-state-board-of-pharmacy-calctapp-2014.